Advertisement
Screener

Eagle Pharmaceuticals, Inc. Research and Development Expense

Eagle Pharmaceuticals, Inc. Research and Development Expense

Eagle Pharmaceuticals, Inc. reported Research and Development Expense of $9.83 million for the 3-month period ending 2023-06-30, per its 10-Q/A filed 2023-08-09.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2023-08-09

  • Eagle Pharmaceuticals, Inc. research and development expense for the quarter ending 2023-06-30 was $9.83M, a 14.02% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. research and development expense for the quarter ending 2023-03-31 was $9.27M, a 51.80% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. research and development expense for the quarter ending 2022-12-31 was $7.22M, a 90.57% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. research and development expense for the quarter ending 2022-09-30 was $9.33M, a 59.96% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. research and development expense for fiscal 2022 was $34.09M, a 33.52% decline from fiscal 2021.
  • Eagle Pharmaceuticals, Inc. research and development expense for fiscal 2021 was $51.27M, a 66.56% increase from fiscal 2020.
  • Eagle Pharmaceuticals, Inc. research and development expense for fiscal 2020 was $30.79M, a 16.37% decline from fiscal 2019.
  • Eagle Pharmaceuticals, Inc. research and development expense for fiscal 2019 was $36.81M, a 17.13% decline from fiscal 2018.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2023-06-30$9.83M
10-Q/A · filed 2023-08-09
$19.11M
10-Q/A · filed 2023-08-09
$26.32M
derived: sum of 3 quarters · filed 2023-08-09
$35.65M
derived: sum of 4 quarters · filed 2023-08-09
2023-03-31$9.27M
10-Q · filed 2023-05-09
$16.49M
derived: sum of 2 quarters · filed 2023-05-09
$25.82M
derived: sum of 3 quarters · filed 2023-05-09
$37.25M
derived: sum of 4 quarters · filed 2023-08-09
2022-12-31$7.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$16.54M
derived: sum of 2 quarters · filed 2023-03-23
$27.98M
derived: sum of 3 quarters · filed 2023-08-09
$34.09M
10-K · filed 2023-03-23
2022-09-30$9.33M
10-Q · filed 2022-11-09
$20.76M
derived: sum of 2 quarters · filed 2023-08-09
$26.87M
10-Q · filed 2022-11-09
$30.66M
derived: sum of 4 quarters · filed 2023-08-09
2022-06-30$11.44M
10-Q/A · filed 2023-08-09
$17.55M
10-Q/A · filed 2023-08-09
$21.33M
derived: sum of 3 quarters · filed 2023-08-09
$44.62M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$6.11M
10-Q · filed 2023-05-09
$9.89M
derived: sum of 2 quarters · filed 2023-05-09
$33.18M
derived: sum of 3 quarters · filed 2023-05-09
$43.09M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$3.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$27.08M
derived: sum of 2 quarters · filed 2023-03-23
$36.99M
derived: sum of 3 quarters · filed 2023-03-23
$51.27M
10-K · filed 2023-03-23
2021-09-30$23.29M
10-Q · filed 2022-11-09
$33.20M
derived: sum of 2 quarters · filed 2022-11-09
$47.49M
10-Q · filed 2022-11-09
$56.88M
derived: sum of 4 quarters · filed 2023-03-23
2021-06-30$9.91M
10-Q · filed 2022-08-09
$24.20M
10-Q · filed 2022-08-09
$33.59M
derived: sum of 3 quarters · filed 2023-03-23
$38.42M
derived: sum of 4 quarters · filed 2023-03-23
2021-03-31$14.29M
10-Q · filed 2022-05-09
$23.68M
derived: sum of 2 quarters · filed 2023-03-23
$28.51M
derived: sum of 3 quarters · filed 2023-03-23
$35.65M
derived: sum of 4 quarters · filed 2023-03-23
2020-12-31$9.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$14.22M
derived: sum of 2 quarters · filed 2023-03-23
$21.36M
derived: sum of 3 quarters · filed 2023-03-23
$30.79M
10-K · filed 2023-03-23
2020-09-30$4.83M
10-Q · filed 2021-11-09
$11.96M
derived: sum of 2 quarters · filed 2021-11-09
$21.39M
10-Q · filed 2021-11-09
$32.70M
derived: sum of 4 quarters · filed 2022-03-08
2020-06-30$7.13M
10-Q · filed 2021-08-09
$16.56M
10-Q · filed 2021-08-09
$27.87M
derived: sum of 3 quarters · filed 2022-03-08
$38.04M
derived: sum of 4 quarters · filed 2022-03-08
2020-03-31$9.43M
10-Q · filed 2021-05-10
$20.73M
derived: sum of 2 quarters · filed 2022-03-08
$30.91M
derived: sum of 3 quarters · filed 2022-03-08
$39.86M
derived: sum of 4 quarters · filed 2022-03-08
2019-12-31$11.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$21.48M
derived: sum of 2 quarters · filed 2022-03-08
$30.43M
derived: sum of 3 quarters · filed 2022-03-08
$36.81M
10-K · filed 2022-03-08
2019-09-30$10.17M
10-Q · filed 2020-11-02
$19.13M
derived: sum of 2 quarters · filed 2020-11-02
$25.50M
10-Q · filed 2020-11-02
$31.36M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30$8.96M
10-Q · filed 2020-08-10
$15.33M
10-Q · filed 2020-08-10
$21.19M
derived: sum of 3 quarters · filed 2021-03-05
$27.17M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31$6.38M
10-Q · filed 2020-05-11
$12.23M
derived: sum of 2 quarters · filed 2021-03-05
$18.21M
derived: sum of 3 quarters · filed 2021-03-05
$33.47M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31$5.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$11.83M
derived: sum of 2 quarters · filed 2021-03-05
$27.10M
derived: sum of 3 quarters · filed 2021-03-05
$44.42M
10-K · filed 2021-03-05
2018-09-30$5.97M
10-Q · filed 2019-11-12
$21.24M
derived: sum of 2 quarters · filed 2019-11-12
$38.56M
10-Q · filed 2019-11-12
$48.00M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$15.27M
10-Q · filed 2019-08-08
$32.59M
10-Q · filed 2019-08-08
$42.03M
derived: sum of 3 quarters · filed 2020-03-02
$50.98M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$17.32M
10-Q · filed 2019-05-07
$26.76M
derived: sum of 2 quarters · filed 2020-03-02
$35.72M
derived: sum of 3 quarters · filed 2020-03-02
$42.40M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$9.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$18.40M
derived: sum of 2 quarters · filed 2020-03-02
$25.08M
derived: sum of 3 quarters · filed 2020-03-02
$32.61M
10-K · filed 2020-03-02
2017-09-30$8.95M
10-Q · filed 2018-11-01
$15.64M
derived: sum of 2 quarters · filed 2018-11-01
$23.16M
10-Q · filed 2018-11-01
$37.84M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$6.68M
10-Q · filed 2018-08-07
$14.21M
10-Q · filed 2018-08-07
$28.89M
derived: sum of 3 quarters · filed 2019-02-28
$32.09M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$7.53M
10-Q · filed 2018-05-10
$22.20M
derived: sum of 2 quarters · filed 2019-02-28
$25.41M
derived: sum of 3 quarters · filed 2019-02-28
$29.21M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$14.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$17.88M
derived: sum of 2 quarters · filed 2019-02-28
$21.68M
derived: sum of 3 quarters · filed 2019-02-28
$28.29M
10-K · filed 2019-02-28
$30.26M
10-K · filed 2017-03-15
2016-09-30$3.21M
10-Q · filed 2017-11-08
$7.01M
derived: sum of 2 quarters · filed 2017-11-08
$13.61M
10-Q · filed 2017-11-08
$21.31M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$3.80M
10-Q · filed 2017-08-09
$3.73M
10-Q · filed 2016-08-09
$9.32M
10-Q · filed 2017-08-09
$10.40M
10-Q · filed 2016-08-09
$18.10M
derived: sum of 3 quarters · filed 2018-02-26
$25.01M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$5.52M
10-Q · filed 2017-05-08
$6.68M
10-Q · filed 2016-05-10
$14.30M
derived: sum of 2 quarters · filed 2018-02-26
$21.21M
derived: sum of 3 quarters · filed 2018-02-26
$27.09M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$8.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$15.69M
derived: sum of 2 quarters · filed 2018-02-26
$21.57M
derived: sum of 3 quarters · filed 2018-02-26
$27.86M
10-K · filed 2018-02-26
2015-09-30$6.91M
10-Q · filed 2016-11-09
$12.79M
derived: sum of 2 quarters · filed 2016-11-09
$19.07M
10-Q · filed 2016-11-09
$23.06M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30$5.88M
10-Q · filed 2016-08-09
$12.16M
10-Q · filed 2016-08-09
$16.15M
derived: sum of 3 quarters · filed 2017-03-15
$22.04M
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31$6.29M
10-Q · filed 2016-05-10
$10.27M
derived: sum of 2 quarters · filed 2017-03-15
$16.16M
derived: sum of 3 quarters · filed 2017-03-15
$20.70M
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31$3.99M
10-K · filed 2017-03-15
$9.87M
derived: sum of 2 quarters · filed 2017-03-15
$14.42M
derived: sum of 3 quarters · filed 2017-03-15
$18.21M
derived: sum of 4 quarters · filed 2017-03-15
2014-09-30$5.89M
10-Q · filed 2015-11-12
$10.43M
derived: sum of 2 quarters · filed 2015-11-12
$14.23M
10-Q · filed 2015-11-12
$16.82M
10-K · filed 2017-03-15
2014-06-30$4.54M
10-Q · filed 2015-08-11
$4.55M
10-Q · filed 2014-08-11
$8.34M
10-Q · filed 2015-08-11
$10.93M
10-Q · filed 2014-08-11
$14.35M
derived: sum of 4 quarters · filed 2017-03-15
2014-03-31$3.79M
10-Q · filed 2015-05-15
$3.79M
10-Q · filed 2014-05-15
$6.38M
10-Q · filed 2014-05-15
$9.80M
derived: sum of 3 quarters · filed 2017-03-15
$11.43M
derived: sum of 4 quarters · filed 2017-03-15
2013-12-31$2.59M
10-K · filed 2017-03-15
$6.01M
derived: sum of 2 quarters · filed 2017-03-15
$7.64M
derived: sum of 3 quarters · filed 2017-03-15
$10.17M
derived: sum of 4 quarters · filed 2017-03-15
2013-09-30$3.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$5.05M
derived: sum of 2 quarters · filed 2016-02-29
$7.58M
derived: sum of 3 quarters · filed 2016-02-29
$9.79M
10-K · filed 2016-02-29
2013-06-30$1.63M
10-Q · filed 2014-08-11
$4.16M
derived: sum of 2 quarters · filed 2014-08-11
$6.38M
10-Q · filed 2014-08-11
2013-03-31$2.53M
10-Q · filed 2014-05-15
$4.74M
10-Q · filed 2014-05-15
2012-09-30$12.80M
10-K · filed 2014-12-22